OKYO
Price:
$1.52
Market Cap:
$58.32M
OKYO Pharma Limited is a biopharmaceutical firm operating at the preclinical stage, dedicated to developing innovative treatments for individuals in the United Kingdom experiencing inflammatory eye conditions and ocular discomfort. Its primary therapeutic candidate is OK-101, specifically designed to address dry eye disease. Additionally, the company is advancing OK-201, an experimental bovine adrenal medulla lipidated-peptide analogue, intended to treat neuropathic ocular pain. Established in 2007, OKYO Pharma Limited maintains its headquarters in London, UK.
Industry
Biotechnology
IPO Date
2022-05-17
Stock Exchange
NASDAQ
Ticker
OKYO
According to OKYO Pharma Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 54.28M. This represents a change of 8.40% compared to the average of 50.07M of the last 4 quarters.
The mean historical Enterprise Value of OKYO Pharma Limited over the last ten years is 32.46M. The current 54.28M Enterprise Value has changed 16.62% with respect to the historical average. Over the past ten years (40 quarters), OKYO's Enterprise Value was at its highest in in the September 2025 quarter at 70.81M. The Enterprise Value was at its lowest in in the March 2010 quarter at -26640042.00.
Average
32.46M
Median
31.81M
Minimum
12.11M
Maximum
51.83M
Discovering the peaks and valleys of OKYO Pharma Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 75.35%
Maximum Annual Enterprise Value = 51.83M
Minimum Annual Increase = -31.39%
Minimum Annual Enterprise Value = 12.11M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 48.59M | 14.85% |
| 2024 | 42.31M | 18.97% |
| 2023 | 35.56M | -31.39% |
| 2022 | 51.83M | 68.96% |
| 2021 | 30.68M | -6.91% |
| 2020 | 32.95M | 17.72% |
| 2019 | 27.99M | 31.28% |
| 2018 | 21.32M | 0.44% |
| 2017 | 21.23M | 75.35% |
| 2016 | 12.11M | -25.33% |
The current Enterprise Value of OKYO Pharma Limited (OKYO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
42.15M
5-year avg
41.79M
10-year avg
32.46M
OKYO Pharma Limited’s Enterprise Value is greater than Tiziana Life Sciences Ltd (-65269000.00), less than Sol-Gel Technologies Ltd. (197.08M), greater than Anebulo Pharmaceuticals, Inc. (10.33M), greater than Coya Therapeutics, Inc. (35.58M), less than Clene Inc. (76.31M), less than Pliant Therapeutics, Inc. (76.56M), less than MacroGenics, Inc. (221.70M), less than Zentalis Pharmaceuticals, Inc. (269.67M), less than Immix Biopharma, Inc. (381.48M), less than Whitehawk Therapeutics Inc (170.93M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| -65269000.00 | $65.37M | |
| 197.08M | $206.36M | |
| 10.33M | $19.37M | |
| 35.58M | $86.31M | |
| 76.31M | $60.20M | |
| 76.56M | $69.97M | |
| 221.70M | $251.71M | |
| 269.67M | $266.95M | |
| 381.48M | $459.70M | |
| 170.93M | $205.72M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like OKYO Pharma Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like OKYO Pharma Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is OKYO Pharma Limited's Enterprise Value?
What is the highest Enterprise Value for OKYO Pharma Limited (OKYO)?
What is the 3-year average Enterprise Value for OKYO Pharma Limited (OKYO)?
What is the 5-year average Enterprise Value for OKYO Pharma Limited (OKYO)?
How does the current Enterprise Value for OKYO Pharma Limited (OKYO) compare to its historical average?